Ares Genetics services and solutions

To enable better infection control and more targeted patient care, Ares Genetics aims to provide unprecedented insight into AMR through next generation sequencing (NGS) and artificial intelligence (AI) powered solutions. Innovative machine learning driven bioinformatics and the extensively curated ARESdb database comprehensively detect and interpret the genetic profile of pathogens. Unlike conventional molecular assays, Ares Genetics solutions not only detect AMR markers but shed light on prevalence and diagnostic performance for these markers and predict how pathogens will respond to therapy.

We are open to discussions about co-development of infectious disease diagnostic solutions and technology licensing opportunities.

Ares Genetics, an OpGen group company, revolutionizes how we address the global challenge of antimicrobial resistance with innovative genome technologies and AI-powered bioinformatics. Ares Genetics offers a portfolio of services and solutions for outbreak surveillance, infection control, AMR prediction, and the targeted delivery of antimicrobial therapy.

ARESdb is a database of AMR biomarkers comprehensively covering resistance genes and mutations. Unlike other databases, ARESdb informs on the diagnostic performance of AMR markers and enables the AI-powered prediction of phenotypic resistance (predictive AST) directly from genome data.

Ares Genetics solutions also include isolate sequencing services (ARESiss), the culture-free universal pathogenome assay (ARESupa) comprehensively screening for pathogen and AMR markers, ARESdb, AREScloud, as well as tailored bioinformatics services.